Literature DB >> 21435753

Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.

Constance Genès1, Gaëlle Lenglet, Sabine Depauw, Raja Nhili, Soizic Prado, Marie-Hélène David-Cordonnier, Sylvie Michel, François Tillequin, François-Hugues Porée.   

Abstract

Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435753     DOI: 10.1016/j.ejmech.2011.02.065

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.

Authors:  Evgeny Kiselev; Nicholas Empey; Keli Agama; Yves Pommier; Mark Cushman
Journal:  J Org Chem       Date:  2012-05-15       Impact factor: 4.354

2.  Design, Synthesis, Molecular Modelling and Anticancer Activities of New Fused Phenanthrolines.

Authors:  Cristina Maria Al Matarneh; Roxana Maria Amarandi; Anda Mihaela Craciun; Ionel I Mangalagiu; Gheorghita Zbancioc; Ramona Danac
Journal:  Molecules       Date:  2020-01-25       Impact factor: 4.411

3.  Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines.

Authors:  Raja Nhili; Paul Peixoto; Sabine Depauw; Sébastien Flajollet; Xavier Dezitter; Manoj M Munde; Mohamed A Ismail; Arvind Kumar; Abdelbasset A Farahat; Chad E Stephens; Martine Duterque-Coquillaud; W David Wilson; David W Boykin; Marie-Hélène David-Cordonnier
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.